Gram Research analysis of a 2,487-patient randomized trial shows that prostate cancer patients with high cholesterol or high blood pressure benefit significantly from routine heart specialist referrals. Men with elevated cholesterol (above 4 mmol/L) who saw a cardiologist experienced a 75% improvement in combined heart health and cholesterol control measures, compared to only 21% improvement for those with normal cholesterol. However, specialist referrals did not reduce heart attacks, strokes, or heart failure deaths overall, the main benefit was better control of cholesterol and blood pressure numbers.
A major study of nearly 2,500 prostate cancer patients found that seeing a heart specialist helps some patients more than others. Researchers discovered that men with prostate cancer who have high cholesterol or high blood pressure benefit the most from routine visits with a cardiologist or internist. The study, called RADICAL PC-2, showed that specialist care improved cholesterol control and blood pressure management, though it didn’t reduce heart attacks or strokes overall. This finding helps doctors identify which patients should prioritize heart health monitoring during cancer treatment.
Key Statistics
A 2026 randomized controlled trial of 2,487 prostate cancer patients found that those with high cholesterol who received routine cardiologist referrals achieved a 75% improvement in combined heart health and cholesterol control, compared to 21% improvement for patients with normal cholesterol levels.
Among 2,487 prostate cancer patients in the RADICAL PC-2 trial, those with baseline blood pressure of 130/80 mm Hg or higher showed significantly better cholesterol and blood pressure control when referred to heart specialists, though major heart events were not reduced.
According to research reviewed by Gram, prostate cancer patients with uncontrolled cholesterol or blood pressure benefited most from specialist cardiovascular care, with treatment effects differing significantly based on baseline cholesterol levels (interaction P = 0.016).
The RADICAL PC-2 trial of 2,487 men found that routine cardiologist referral improved cholesterol control in prostate cancer patients but did not reduce rates of heart attacks, strokes, or heart failure compared to standard care.
The Quick Take
- What they studied: Whether prostate cancer patients should see a heart specialist to manage their heart health and lifestyle during cancer treatment
- Who participated: 2,487 men with prostate cancer or receiving hormone therapy, divided into two groups, one that got routine heart specialist referrals and one that didn’t
- Key finding: Men with high cholesterol (above 4 mmol/L) or high blood pressure who saw a heart specialist had significantly better outcomes, with a 75% improvement in the combined measure of heart health and cholesterol control
- What it means for you: If you have prostate cancer and high cholesterol or high blood pressure, asking your cancer doctor for a heart specialist referral could help you manage these conditions better. However, this doesn’t prevent heart attacks or strokes, it mainly helps control cholesterol and blood pressure numbers.
The Research Details
Researchers randomly assigned 2,487 prostate cancer patients into two groups. One group received routine referrals to see a cardiologist (heart specialist) or internist (general internal medicine doctor) for heart health and lifestyle counseling. The other group received standard cancer care without these specialist referrals. The study followed patients for several years, tracking their heart health, cholesterol levels, blood pressure, and whether they experienced heart attacks, strokes, or heart failure.
The researchers specifically looked at whether certain groups of patients benefited more from specialist care than others. They examined patients based on their starting cholesterol levels and blood pressure readings to see if those with worse numbers got more benefit from seeing a heart specialist.
This approach, called a ‘pragmatic randomized trial,’ tests real-world medical practice rather than ideal laboratory conditions. It helps doctors understand which patients in their actual clinics should get specialist referrals.
Prostate cancer patients often receive hormone therapy that can increase heart disease risk. Knowing which patients benefit most from heart specialist care helps doctors make smarter decisions about referrals and helps patients understand whether they should ask for this extra care. Rather than sending all patients to heart specialists, doctors can focus on those most likely to benefit.
This was a well-designed randomized controlled trial, which is considered strong scientific evidence. The large sample size of 2,487 patients provides reliable results. The study was published in a peer-reviewed cardiology journal. However, the study measured improvements in cholesterol and blood pressure control rather than preventing major heart events, which is an important limitation.
What the Results Show
The study found that patients with high cholesterol (above 4 mmol/L) who saw a heart specialist had much better outcomes. Their combined score for heart health and cholesterol control improved by 75% compared to those who didn’t see a specialist. In contrast, patients with normal cholesterol levels showed only a 21% improvement, suggesting they benefited less from specialist care.
Patients with high blood pressure (systolic pressure of 130 mm Hg or higher, or diastolic pressure of 80 mm Hg or higher) also showed better results from specialist referrals. These patients had better cholesterol and blood pressure control when they saw a heart specialist.
Interestingly, the specialist referrals did not reduce the rates of heart attacks, strokes, or heart failure deaths in the overall group. The main benefit was better control of cholesterol and blood pressure numbers, which are important risk factors but not the same as preventing major heart events.
Patients with diabetes who had high blood pressure showed a trend toward fewer major heart events when referred to specialists, though this finding was not statistically definitive.
The study found that cholesterol control was the strongest driver of improvement in the specialist referral group. Patients who saw heart specialists were more likely to reach target cholesterol levels. Blood pressure control also improved, though the effect was somewhat smaller. The combination of better cholesterol and blood pressure management appeared to be the main benefit of specialist care.
This study builds on earlier research showing that heart disease is a major concern for prostate cancer patients, especially those receiving hormone therapy. Previous studies suggested that managing heart risk factors is important, but this is one of the first large trials to test whether routine specialist referrals actually help. The finding that specialist care helps some patients more than others is new and practical information for doctors.
The study did not find that specialist referrals prevented heart attacks, strokes, or heart failure, only that they improved cholesterol and blood pressure numbers. This means we don’t yet know if better cholesterol and blood pressure control will prevent heart problems in the long run. The study followed patients for a limited time, so longer-term benefits are unknown. Additionally, the study was conducted in specific healthcare settings, so results may not apply everywhere.
The Bottom Line
If you have prostate cancer and high cholesterol or high blood pressure, ask your cancer doctor about a referral to a cardiologist or internist for heart health management. This appears to help control these risk factors, though it’s not proven to prevent heart attacks or strokes. If your cholesterol and blood pressure are already well-controlled, the benefit of specialist referral is less clear. (Moderate confidence based on this single trial)
Prostate cancer patients receiving hormone therapy with high cholesterol or high blood pressure should prioritize heart specialist referrals. Patients with normal cholesterol and blood pressure may benefit less. All prostate cancer patients should discuss heart health with their cancer doctors, but specialist referral appears most valuable for those with uncontrolled risk factors.
Improvements in cholesterol and blood pressure control can occur within weeks to months of starting specialist care and medication adjustments. However, the long-term benefit for preventing heart disease may take years to become apparent. Regular monitoring and follow-up appointments are important.
Frequently Asked Questions
Should all prostate cancer patients see a heart doctor?
Not necessarily. Research shows that prostate cancer patients with high cholesterol or high blood pressure benefit most from heart specialist referrals. Those with normal cholesterol and blood pressure may benefit less. Discuss your individual risk factors with your cancer doctor to decide if a referral makes sense for you.
Can seeing a cardiologist prevent heart attacks in prostate cancer patients?
This study didn’t show that specialist referrals prevent heart attacks or strokes. The main benefit was better control of cholesterol and blood pressure numbers. While controlling these risk factors is important for long-term heart health, the study didn’t prove it prevents major heart events.
What’s the difference between seeing a cardiologist and an internist for heart health?
Both can help manage heart health and risk factors in prostate cancer patients. Cardiologists specialize in heart disease, while internists are general internal medicine doctors. This study found both types of specialists helped improve cholesterol and blood pressure control.
How long does it take to see benefits from heart specialist care?
Cholesterol and blood pressure improvements can occur within weeks to months after starting specialist care and adjusting medications. However, the long-term benefit for preventing heart disease may take years to become apparent, so regular monitoring is important.
Does hormone therapy for prostate cancer increase heart disease risk?
Yes, hormone therapy used to treat prostate cancer can increase the risk of heart disease and high cholesterol. This is why managing heart health and risk factors is especially important for prostate cancer patients receiving this treatment.
Want to Apply This Research?
- Track your cholesterol and blood pressure readings monthly if you have a heart specialist referral. Record the date, cholesterol level, systolic and diastolic blood pressure, and any medication changes to monitor progress toward target numbers.
- If referred to a heart specialist, set a reminder to schedule and attend appointments, bring a list of current medications, and track when you start new heart medications or adjust doses. Share these records with both your cancer doctor and heart specialist.
- Create a long-term tracking system that shows your cholesterol and blood pressure trends over 6-12 months. Compare your numbers to your target goals set by your heart specialist. Share this data during follow-up appointments to assess whether specialist care is helping you reach your targets.
This article summarizes research findings and should not replace professional medical advice. Prostate cancer patients should discuss heart health screening, specialist referrals, and treatment options with their oncologist and primary care doctor. Individual recommendations depend on personal risk factors, medical history, and current medications. This study measured improvements in cholesterol and blood pressure control but did not demonstrate prevention of heart attacks or strokes. Always consult with qualified healthcare providers before making medical decisions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.
